EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications

Duarte R S Almeida, João Ferreira Gil, Antonio José Guillot, Jiachen Li, Ricardo J B Pinto iD, Hélder A Santos iD, Gil Gonçalves

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202400946 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Duarte R S Almeida und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Mechanical Technology and Automation (TEMA), Mechanical Engineering Department, University of Aveiro, Aveiro, 3810-193, Portugal. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, UMCG Research Funds, Research Council Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current research in cancer therapy focuses on personalized therapies, through nanotechnology‐based targeted drug delivery systems. Particularly, controlled drug release with nanoparticles (NPs) can be designed to safely transport various active agents, optimizing delivery to specific organs and tumors, minimizing side effects. The use of microfluidics (MFs) in this field has stood out against conventional methods by allowing precise control over parameters like size, structure, composition, and mechanical/biological properties of nanoscale carriers. This review compiles applications of microfluidics in the production of core‐shell NPs (CSNPs) for cancer therapy, discussing the versatility inherent in various microchannel and/or micromixer setups and showcasing how these setups can be utilized individually or in combination, as well as how this technology allows the development of new advances in more efficient and controlled fabrication of core‐shell nanoformulations. Recent biological studies have achieved an effective, safe, and controlled delivery of otherwise unreliable encapsulants such as small interfering RNA (siRNA), plasmid DNA (pDNA), and cisplatin as a result of precisely tuned fabrication of nanocarriers, showing that this technology is paving the way for innovative strategies in cancer therapy nanofabrication, characterized by continuous production and high reproducibility. Finally, this review analyzes the technical, biological, and technological limitations that currently prevent this technology from becoming the standard.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanoparticlesHumansMicrofluidicsAnimalsDrug Delivery SystemsDrug CarriersAntineoplastic Agents

Stichwörter der Autor:innen

multiphasic nanoparticlesnanomedicinetheragnostic microfluidicstumor targeting

Substanzen

Drug CarriersAntineoplastic Agents

Autor:innen und Institutionen

  • Centre for Mechanical Technology and Automation (TEMA), Mechanical Engineering Department, University of Aveiro, Aveiro, 3810-193, Portugal.
  • Intelligent Systems Associate Laboratory (LASI), Guimarães, 4800-058, Portugal.
  • Department of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Ave. Vicent Andrés Estellés s/n, Burjassot, Valencia, 46100, Spain.
  • Department of Biomaterials and Biomedical Technology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, 9713 AV, The Netherlands.
  • CICECO-Aveiro Institute of Materials, Chemistry Department, University of Aveiro, Aveiro, 3810-193, Portugal.
  • Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, 00014, Finland.

ORCID-Profile: Ricardo J B Pinto, Hélder A Santos

Förderung

  • Fundação para a Ciência e a Tecnologia
  • UMCG Research Funds
  • Research Council Finland

Zitieren

APA

Almeida, D. R. S., Gil, J. F., Guillot, A. J., Li, J., Pinto, R. J. B., Santos, H. A., & Gonçalves, G. (2024). Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202400946

Vancouver

Almeida DRS, Gil JF, Guillot AJ, Li J, Pinto RJB, Santos HA, et al. Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202400946

BibTeX
@article{Almeida2024,
  author = {Almeida, Duarte R S and Gil, João Ferreira and Guillot, Antonio José and Li, Jiachen and Pinto, Ricardo J B and Santos, Hélder A and Gonçalves, Gil},
  title = {Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202400946}
}
Kostenlos starten →